PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS.

Authors: Minerva Montalvo Saavedra, Alvaro Bienert Garcia, Belén Pérez-Pinilla, Paula Reyes González-Casanova, Marta Díaz-Lopez, Jose Gregorio Torres Quiroz, Alberto Martinez Llorens, Cielo de Los Ángeles Lorena Borja Goyeneche, Carolina Lacalzada Higueras, Bernardo Javier González González, Miguel Teodoro Hernandez Garcia, Sunil Lakhwani Lakhwani

Published: 2023-08-23

DOI: 10.1097/01.hs9.0000974424.53907.97

Source: Full article

---

Abstract

No abstract found.